These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 21231894)
1. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL. Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894 [TBL] [Abstract][Full Text] [Related]
2. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975 [TBL] [Abstract][Full Text] [Related]
3. Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients. Yassin LM; Rojas M; Ramírez LA; García LF; Vásquez G Cell Immunol; 2010; 266(1):52-60. PubMed ID: 20863485 [TBL] [Abstract][Full Text] [Related]
4. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients. Hayek T; Aviram M; Heinrich R; Sakhnini E; Keidar S Biochem Biophys Res Commun; 2000 Jul; 273(2):417-20. PubMed ID: 10873620 [TBL] [Abstract][Full Text] [Related]
5. CD36 and macrophages in atherosclerosis. Collot-Teixeira S; Martin J; McDermott-Roe C; Poston R; McGregor JL Cardiovasc Res; 2007 Aug; 75(3):468-77. PubMed ID: 17442283 [TBL] [Abstract][Full Text] [Related]
6. CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease. Teupser D; Mueller MA; Koglin J; Wilfert W; Ernst J; von Scheidt W; Steinbeck G; Seidel D; Thiery J Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):552-6. PubMed ID: 18067591 [TBL] [Abstract][Full Text] [Related]
7. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. Soep JB; Mietus-Snyder M; Malloy MJ; Witztum JL; von Scheven E Arthritis Rheum; 2004 Jun; 51(3):451-7. PubMed ID: 15188333 [TBL] [Abstract][Full Text] [Related]
8. Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmune-mediated atherosclerosis. Lopez LR; Buckner TR; Hurley BL; Kobayashi K; Matsuura E Ann N Y Acad Sci; 2007 Aug; 1109():303-10. PubMed ID: 17785319 [TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060 [TBL] [Abstract][Full Text] [Related]
10. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nosadini R; Tonolo G Nutr Metab Cardiovasc Dis; 2011 Feb; 21(2):79-85. PubMed ID: 21186102 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290 [TBL] [Abstract][Full Text] [Related]
13. Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus. Li J; Fu Q; Cui H; Qu B; Pan W; Shen N; Bao C Arthritis Rheum; 2011 Feb; 63(2):492-502. PubMed ID: 21280004 [TBL] [Abstract][Full Text] [Related]
14. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721 [TBL] [Abstract][Full Text] [Related]
16. The in vitro effect of oxidized LDL and PHA on proliferation and gene expression of regulatory T cells in patients with atherosclerosis. Mottaghi A; Salehi E; Sezavar H; Keshavarz SA; Eshraghian MR; Rezaei N; Rejali L; Saboor-Yaraghi AA Iran J Allergy Asthma Immunol; 2012 Sep; 11(3):217-23. PubMed ID: 22947906 [TBL] [Abstract][Full Text] [Related]
17. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Posadas-Romero C; Torres-Tamayo M; Zamora-González J; Aguilar-Herrera BE; Posadas-Sánchez R; Cardoso-Saldaña G; Ladrón de Guevara G; Solis-Vallejo E; El Hafidi M Arthritis Rheum; 2004 Jan; 50(1):160-5. PubMed ID: 14730612 [TBL] [Abstract][Full Text] [Related]
18. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL; Mason JC; Davies KA Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. Hahn BH; Grossman J; Chen W; McMahon M J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]